Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencie ...
A Multicenter Extension Study on the Safety and Efficacy of IgPro10 in Patients With Primary Immunodeficiency (PID) A Multicenter Extension Study on the Safety and Efficacy of IgPro10 in Patients With Primary Immunod ...
Primary Immune Deficiency (Common Variable Immunodeficiency and X-linked agammaglobulinemia) MedDRA version: 17.1;Level: PT;Classification code 10064859;Term: Primary immunodeficiency syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Primary Immune Deficiency (Common Variable Immunodeficiency and X-linked agammaglobulinemia) MedDRA ...
The pharmacokinetics and safety of intravenous IgPro10 in Japanese subjects with primary immunodeficiency The pharmacokinetics and safety of intravenous IgPro10 in Japanese subjects with primary immunodefic ...
Prospective open-label single-arm study of the pharmacokinetics and safety of intravenous IgPro10 in Japanese subjects with primary immunodeficiency Prospective open-label single-arm study of the pharmacokinetics and safety of intravenous IgPro10 in ...
Primary immunodeficiency MedDRA version: 19.1;Level: PT;Classification code 10064859;Term: Primary immunodeficiency syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Primary immunodeficiency MedDRA version: 19.1;Level: PT;Classification code 10064859;Term: Primary i ...